GlassScriptPhysician profile
James F Lawless
NPI 1114910874
$820.30
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $79.63 · 2021: $284 · 2022: $317.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $123.30 | 2021-2022 | |
| Glaxosmithkline, LLC. | $99.00 | 2019-2022 | |
| Irhythm Technologies, INC. | $83.19 | 2022 | |
| Amarin Pharma, INC. | $54.35 | 2019-2021 | |
| Amgen INC. | $49.40 | 2019-2021 | |
| Novo Nordisk INC | $46.12 | 2021-2022 | |
| Lilly USA, LLC | $43.79 | 2019-2020 | |
| Pfizer INC. | $42.15 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $37.63 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.91 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.85 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.34 | 2021 | |
| Arbor Pharmaceuticals, INC. | $26.07 | 2020-2021 | |
| Incyte Corporation | $22.75 | 2022 | |
| Allergan, INC. | $20.03 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.97 | 2019 | |
| Upsher-Smith Laboratories LLC | $18.09 | 2021 | |
| Bausch Health US, LLC | $16.18 | 2021 | |
| Ibsa Pharma INC. | $14.13 | 2021 | |
| Merck Sharp & Dohme LLC | $13.05 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lawless listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.